Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for Sleep and Pain in Neuropathic Pain
NCT06155916Recruiting
- Sponsor
- Helsinki University Hospital
- Start
- Nov 2022
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of pregabalin in neuropathic pain (2 arms), sponsored by Helsinki University Hospital. Primary endpoints: Pregabalin response to pain, Pregabalin effect on sleep stages and 4 more. Started Nov 2022; status: recruiting.
02
Drugs
pregabalin
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT06155916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06155916.